201 related articles for article (PubMed ID: 30427124)
1. Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease.
Magvanjav O; Cooper-DeHoff RM; McDonough CW; Gong Y; Segal MS; Hogan WR; Johnson JA
J Clin Hypertens (Greenwich); 2019 Jan; 21(1):91-101. PubMed ID: 30427124
[TBL] [Abstract][Full Text] [Related]
2. A feared combination: Hypertension and chronic kidney disease.
Varleta P; Tagle R
J Clin Hypertens (Greenwich); 2019 Jan; 21(1):102-104. PubMed ID: 30427110
[No Abstract] [Full Text] [Related]
3. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
5. Choice of antihypertensive medications among physicians and its impact on blood pressure control among Nigerians living with hypertension.
Mijinyawa Muhammad S; Yusuf MS; Mohammed H; Saidu H; Sulaiman BA; Uloko AE
Niger J Med; 2016; 25(3):220-5. PubMed ID: 30011166
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis.
Chang TI; Zheng Y; Montez-Rath ME; Winkelmayer WC
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1401-1412. PubMed ID: 27354656
[TBL] [Abstract][Full Text] [Related]
7. Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey.
Sonawane KB; Qian J; Hansen RA
Clin Ther; 2015 Jan; 37(1):188-96. PubMed ID: 25524390
[TBL] [Abstract][Full Text] [Related]
8. Managing Hypertension Using Combination Therapy.
Smith DK; Lennon RP; Carlsgaard PB
Am Fam Physician; 2020 Mar; 101(6):341-349. PubMed ID: 32163253
[TBL] [Abstract][Full Text] [Related]
9. Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study.
Arney J; Gregg LP; Wydermyer S; Herrera MA; Richardson PA; Matheny ME; Akeroyd JM; Gobbel GT; Hung A; Virani SS; Navaneethan SD
Cardiorenal Med; 2024; 14(1):34-44. PubMed ID: 38151011
[TBL] [Abstract][Full Text] [Related]
10. Hypertension Management in Transition: From CKD to ESRD.
Valika A; Peixoto AJ
Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
Lu Y; Van Zandt M; Liu Y; Li J; Wang X; Chen Y; Chen Z; Cho J; Dorajoo SR; Feng M; Hsu MH; Hsu JC; Iqbal U; Jonnagaddala J; Li YC; Liaw ST; Lim HS; Ngiam KY; Nguyen PA; Park RW; Pratt N; Reich C; Rhee SY; Sathappan SMK; Shin SJ; Tan HX; You SC; Zhang X; Krumholz HM; Suchard MA; Xu H
JAMA Netw Open; 2022 Mar; 5(3):e223877. PubMed ID: 35323951
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
Omae K; Ogawa T; Nitta K
Heart Vessels; 2010 May; 25(3):203-8. PubMed ID: 20512447
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
[TBL] [Abstract][Full Text] [Related]
15. Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.
Bhandari S; Ives N; Brettell EA; Valente M; Cockwell P; Topham PS; Cleland JG; Khwaja A; El Nahas M
Nephrol Dial Transplant; 2016 Feb; 31(2):255-61. PubMed ID: 26429974
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic Issues in treating hypertension in CKD.
Sica DA
Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
[TBL] [Abstract][Full Text] [Related]
17. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
18. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
19. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
